Clinical assessment of efficacy and safety of DDAVP.

  title={Clinical assessment of efficacy and safety of DDAVP.},
  author={Wolfgang Miesbach and Sebastian Krekeler and O. D{\"u}ck and B. Llugaliu and G. Mebrahitom Asmelash and J{\"o}rg Sch{\"u}ttrumpf and Sonja Alesci and Rog{\'e}rio Grossmann},
  volume={30 Suppl 1},
UNLABELLED The efficacy of DDAVP (1-deamino-8-D-arginine-vasopressin, desmopressin) in mild haemophilia A and von Willebrand disease (VWD) has been established and the use of this well tolerated drug has become clinical routine. In case of increased fluid intake and based on very rarely occurring hyponatraemia, the indication of administration of DDAVP intravenously (i. v.) has to be performed diligently in elderly patients and in children below the age of five years. Aim, patients: Due to… CONTINUE READING